| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.18B | 21.59B | 27.10B | 28.33B | 36.25B | 25.96B |
| Gross Profit | 6.08B | 7.29B | 9.65B | 9.74B | 17.05B | 7.60B |
| EBITDA | 11.05B | 11.36B | 12.72B | 14.54B | 22.16B | 13.89B |
| Net Income | 4.71B | 2.37B | 3.04B | 4.67B | 13.22B | 2.31B |
Balance Sheet | ||||||
| Total Assets | 80.46B | 86.78B | 85.44B | 74.01B | 72.61B | 75.04B |
| Cash, Cash Equivalents and Short-Term Investments | 3.81B | 1.99B | 2.13B | 1.43B | 984.00M | 2.76B |
| Total Debt | 15.67B | 23.96B | 27.10B | 20.91B | 20.77B | 30.39B |
| Total Liabilities | 40.90B | 50.19B | 50.97B | 43.66B | 42.52B | 54.71B |
| Stockholders Equity | 38.93B | 36.03B | 34.16B | 30.25B | 30.09B | 20.33B |
Cash Flow | ||||||
| Free Cash Flow | 3.57B | 4.11B | 4.42B | 6.06B | 12.46B | 7.56B |
| Operating Cash Flow | 9.66B | 10.53B | 11.44B | 12.31B | 16.81B | 10.43B |
| Investing Cash Flow | 2.78B | -5.80B | -14.59B | -6.98B | -4.87B | -1.25B |
| Financing Cash Flow | -11.24B | -4.84B | 3.84B | -4.89B | -13.71B | -8.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $74.71B | 9.71 | 18.28% | 3.79% | 0.31% | -5.71% | |
73 Outperform | $43.36B | 5.27 | 7.67% | 6.85% | -7.02% | -23.68% | |
69 Neutral | $59.38B | 4.74 | 12.82% | 2.39% | -15.17% | -66.00% | |
69 Neutral | $57.06B | 65.10 | 14.78% | 2.64% | 1.96% | -18.06% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
62 Neutral | $57.84B | 97.11 | 1.06% | 2.70% | 18.09% | -94.57% |